Lataa...
Intravenous Clomipramine for Treatment-Resistant Obsessive-Compulsive Disorder
BACKGROUND: This open trial was conducted to evaluate the effectiveness of intravenous clomipramine (CMI) in refractory obsessive-compulsive disorder (OCD). METHODS: Thirty OCD poor responders to previous multiple trials of anti-obsessive medications were selected and admitted to the hospital. Sever...
Tallennettuna:
| Julkaisussa: | Int J Neuropsychopharmacol |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Oxford University Press
2015
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4772819/ https://ncbi.nlm.nih.gov/pubmed/26221004 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ijnp/pyv084 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|